Opthea Ltd (OPT) ニュース

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Opthea to Receive US$35M Commitment and Additional US$50M Funding

Opthea to receive remaining US$35m funding under the Development Funding Agreement (DFA) with Carlyle and its...

Opthea Receives A$8.8 million R&D Tax Incentive

MELBOURNE, Australia, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq:OPT), a clinical...

Opthea to Present at the FLORetina 2023 Congress

MELBOURNE, Australia, Dec. 01, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; NASDAQ:OPT), a clinical...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Opthea to Present at the Jefferies 2023 London Healthcare Conference

MELBOURNE, Australia, Nov. 09, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical...

Opthea to Present at Eyecelerator Forum at the 2023 American Academy of Ophthalmology (AAO) Conference

MELBOURNE, Australia, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Opthea Appoints U.S.-Based Leadership with Fred Guerard as CEO and Peter Lang as CFO

Dr. Megan Baldwin transitions to Founder, Chief Innovation Officer and remains on the Board of Directors...

Opthea to Participate at the 2023 Euretina Congress

MELBOURNE, Australia, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

Opthea to Present at the H.C. Wainwright 25th Annual Global Investment Conference

MELBOURNE, Australia, Sept. 07, 2023 (GLOBE NEWSWIRE) -- Opthea Limited (NASDAQ:OPT; ASX:OPT), a clinical...

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]